These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

451 related articles for article (PubMed ID: 27017251)

  • 1. Digital breast tomosynthesis (3D-mammography) screening: A pictorial review of screen-detected cancers and false recalls attributed to tomosynthesis in prospective screening trials.
    Houssami N; Lång K; Bernardi D; Tagliafico A; Zackrisson S; Skaane P
    Breast; 2016 Apr; 26():119-34. PubMed ID: 27017251
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of integrating 3D-mammography (digital breast tomosynthesis) with 2D-mammography on radiologists' true-positive and false-positive detection in a population breast screening trial.
    Bernardi D; Caumo F; Macaskill P; Ciatto S; Pellegrini M; Brunelli S; Tuttobene P; Bricolo P; Fantò C; Valentini M; Montemezzi S; Houssami N
    Eur J Cancer; 2014 May; 50(7):1232-8. PubMed ID: 24582915
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Radiologists' interpretive efficiency and variability in true- and false-positive detection when screen-reading with tomosynthesis (3D-mammography) relative to standard mammography in population screening.
    Svahn TM; Macaskill P; Houssami N
    Breast; 2015 Dec; 24(6):687-93. PubMed ID: 26433751
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of integrating digital breast tomosynthesis (3D-mammography) with acquired or synthetic 2D-mammography on radiologists' true-positive and false-positive detection in a population screening trial: A descriptive study.
    Bernardi D; Li T; Pellegrini M; Macaskill P; Valentini M; Fantò C; Ostillio L; Houssami N
    Eur J Radiol; 2018 Sep; 106():26-31. PubMed ID: 30150047
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Integration of 3D digital mammography with tomosynthesis for population breast-cancer screening (STORM): a prospective comparison study.
    Ciatto S; Houssami N; Bernardi D; Caumo F; Pellegrini M; Brunelli S; Tuttobene P; Bricolo P; Fantò C; Valentini M; Montemezzi S; Macaskill P
    Lancet Oncol; 2013 Jun; 14(7):583-9. PubMed ID: 23623721
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Interval breast cancers in the 'screening with tomosynthesis or standard mammography' (STORM) population-based trial.
    Houssami N; Bernardi D; Caumo F; Brunelli S; Fantò C; Valentini M; Romanucci G; Gentilini MA; Zorzi M; Macaskill P
    Breast; 2018 Apr; 38():150-153. PubMed ID: 29328943
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Breast screening using 2D-mammography or integrating digital breast tomosynthesis (3D-mammography) for single-reading or double-reading--evidence to guide future screening strategies.
    Houssami N; Macaskill P; Bernardi D; Caumo F; Pellegrini M; Brunelli S; Tuttobene P; Bricolo P; Fantò C; Valentini M; Ciatto S
    Eur J Cancer; 2014 Jul; 50(10):1799-1807. PubMed ID: 24746887
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Breast cancers detected in only one of two arms of a tomosynthesis (3D-mammography) population screening trial (STORM-2).
    Bernardi D; Houssami N
    Breast; 2017 Apr; 32():98-101. PubMed ID: 28107735
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Incremental effect from integrating 3D-mammography (tomosynthesis) with 2D-mammography: Increased breast cancer detection evident for screening centres in a population-based trial.
    Caumo F; Bernardi D; Ciatto S; Macaskill P; Pellegrini M; Brunelli S; Tuttobene P; Bricolo P; Fantò C; Valentini M; Montemezzi S; Houssami N
    Breast; 2014 Feb; 23(1):76-80. PubMed ID: 24316152
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Breast cancer screening with tomosynthesis (3D mammography) with acquired or synthetic 2D mammography compared with 2D mammography alone (STORM-2): a population-based prospective study.
    Bernardi D; Macaskill P; Pellegrini M; Valentini M; Fantò C; Ostillio L; Tuttobene P; Luparia A; Houssami N
    Lancet Oncol; 2016 Aug; 17(8):1105-1113. PubMed ID: 27345635
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Discordant and false-negative interpretations at digital breast tomosynthesis in the prospective Oslo Tomosynthesis Screening Trial (OTST) using independent double reading.
    Skaane P; Østerås BH; Yanakiev S; Lie T; Eben EB; Gullien R; Brandal SHB
    Eur Radiol; 2024 Jun; 34(6):3912-3923. PubMed ID: 37938385
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clinical performance metrics of 3D digital breast tomosynthesis compared with 2D digital mammography for breast cancer screening in community practice.
    Greenberg JS; Javitt MC; Katzen J; Michael S; Holland AE
    AJR Am J Roentgenol; 2014 Sep; 203(3):687-93. PubMed ID: 24918774
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Breast cancer detection using single-reading of breast tomosynthesis (3D-mammography) compared to double-reading of 2D-mammography: Evidence from a population-based trial.
    Houssami N; Bernardi D; Pellegrini M; Valentini M; Fantò C; Ostillio L; Tuttobene P; Luparia A; Macaskill P
    Cancer Epidemiol; 2017 Apr; 47():94-99. PubMed ID: 28192742
    [TBL] [Abstract][Full Text] [Related]  

  • 14. One-view breast tomosynthesis versus two-view mammography in the Malmö Breast Tomosynthesis Screening Trial (MBTST): a prospective, population-based, diagnostic accuracy study.
    Zackrisson S; Lång K; Rosso A; Johnson K; Dustler M; Förnvik D; Förnvik H; Sartor H; Timberg P; Tingberg A; Andersson I
    Lancet Oncol; 2018 Nov; 19(11):1493-1503. PubMed ID: 30322817
    [TBL] [Abstract][Full Text] [Related]  

  • 15. False positives in breast cancer screening with one-view breast tomosynthesis: An analysis of findings leading to recall, work-up and biopsy rates in the Malmö Breast Tomosynthesis Screening Trial.
    Lång K; Nergården M; Andersson I; Rosso A; Zackrisson S
    Eur Radiol; 2016 Nov; 26(11):3899-3907. PubMed ID: 26943342
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A prospective comparative trial of adjunct screening with tomosynthesis or ultrasound in women with mammography-negative dense breasts (ASTOUND-2).
    Tagliafico AS; Mariscotti G; Valdora F; Durando M; Nori J; La Forgia D; Rosenberg I; Caumo F; Gandolfo N; Sormani MP; Signori A; Calabrese M; Houssami N
    Eur J Cancer; 2018 Nov; 104():39-46. PubMed ID: 30316869
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Breast cancer screening using tomosynthesis in combination with digital mammography.
    Friedewald SM; Rafferty EA; Rose SL; Durand MA; Plecha DM; Greenberg JS; Hayes MK; Copit DS; Carlson KL; Cink TM; Barke LD; Greer LN; Miller DP; Conant EF
    JAMA; 2014 Jun; 311(24):2499-507. PubMed ID: 25058084
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Overview of the evidence on digital breast tomosynthesis in breast cancer detection.
    Houssami N; Skaane P
    Breast; 2013 Apr; 22(2):101-108. PubMed ID: 23422255
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Digital breast tomosynthesis (DBT): initial experience in a clinical setting.
    Skaane P; Gullien R; Bjørndal H; Eben EB; Ekseth U; Haakenaasen U; Jahr G; Jebsen IN; Krager M
    Acta Radiol; 2012 Jun; 53(5):524-9. PubMed ID: 22593120
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pilot trial of digital breast tomosynthesis (3D mammography) for population-based screening in BreastScreen Victoria.
    Houssami N; Lockie D; Clemson M; Pridmore V; Taylor D; Marr G; Evans J; Macaskill P
    Med J Aust; 2019 Oct; 211(8):357-362. PubMed ID: 31448816
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 23.